首页 | 官方网站   微博 | 高级检索  
     

骨标志物在乳腺癌骨转移诊断与疗效观察中的作用
引用本文:迟伟群,王福莉,隋晓凤,于晓斐,张超民,姚玉虹.骨标志物在乳腺癌骨转移诊断与疗效观察中的作用[J].实用肿瘤学杂志,2012,26(5):414-417.
作者姓名:迟伟群  王福莉  隋晓凤  于晓斐  张超民  姚玉虹
作者单位:1.哈尔滨医科大学附属第四医院检验科(哈尔滨 150001);2.哈尔滨市第五医院
基金项目:基金项目:黑龙江省卫生厅项目(2010-121)
摘    要:目的 探讨I型胶原交联羧基氨基端肽(β-Cross Laps)和总骨1型前胶原氨基端延长肽(P1NP)在乳腺癌骨转移诊断与疗效观察中的临床价值。方法 运用电化学发光法对β-Cross Laps、P1NP、CA15-3进行定量检测。57例乳腺癌骨转移患者按转移灶多少分为2组,分别为骨显像轻度异常组(Ⅰ组)36例与骨显像明显异常组(Ⅱ组)21例。结果 骨转移组β-Cross Laps、P1NP两种血清标志物较无骨转移组与对照组明显升高,差异具有统计学意义(P<0.01),且治疗后两种指标明显低于治疗前水平(P<0.05),随转移灶增加两种标志物水平也有升高趋势,差异具有统计学意义(P<0.01)。而各组间及治疗前后CA15-3无显著变化(P>0.05)。骨标志物β-Cross Laps、P1NP对乳腺癌骨转移的诊断灵敏度分别达到71.25%与64.05%,特异性分别达到88.00%与81.99%,均高于骨显像所显示结果的50.32%和61.17%。结论 血清骨标志物β-Cross Laps、P1NP水平可以反映乳腺癌骨转移患者病情变化,并可以运用于疗效监测,有较好的临床应用价值。

关 键 词:I型胶原交联羧基氨基端肽  总骨1型前胶原氨基端延长肽  乳腺癌骨转移  
收稿时间:2012-03-20

The effectiveness of bone marker in the diagnosing and observing therapeutic effect of bone metastatic carcinoma
CHI Weiqun,WANG Fuli,SUI Xiaofeng,YU Xiaofei,ZHANG Chaomin,YAO Yuhong.The effectiveness of bone marker in the diagnosing and observing therapeutic effect of bone metastatic carcinoma[J].Journal of Practical Oncology,2012,26(5):414-417.
Authors:CHI Weiqun  WANG Fuli  SUI Xiaofeng  YU Xiaofei  ZHANG Chaomin  YAO Yuhong
Affiliation:1.Department of Clinical Lab,The Fourth Affiliated Hospital of Harbin Medical University,Harbin 150001,China;2.The Fifth Hospital of Harbin
Abstract:Objective To investigate the clinical value of β -Cross Laps and P1NP in diagnosing and observing therapeutic effect of bone metastatic carcinoma. Methods Detecting β - Cross Laps, P1NP, CA15 - 3 quantitatively using the electrochemiluminescence. All the 57 patient with bone metastatic carcinoma were divided into two grouos. One( I )for 36 were with lighter abnormality of bone imaging. The other( II )were remarkableness of bone imaging. Results The concentrations of β - Cross Laps and P1NP in the group one are obviously higher than the group two and control group. The discrepancy have the statistical significance (P 〈 0.01 ). And the concentrations of the two marker aftertherapy are also obviously lower than the concentrations before therapy (P 〈 0.05 ), the concentrations of the two marker are also having the increasing tendency followed by the creasing of metastasis. The discrepancy have the statistical significance ( P 〈 0.01 ). There are no significantly changes of CA15 -3 in different groups(P 〉0.05). The sensibility of β - Cross Laps and P1NP might reached at 71.25% and 64.05%. The specificity of them might reached at 88.0% and 81.99%. Both are higher than the results of bone imaging for 50.32% and 61.17%. Conclusion The concentrations of β - Cross Laps and P1NP might reflect the alleosis of the patients of bone metastatic carcinoma. It can be used for monitoring therapeutic effect, having better clinical application worth.
Keywords:β- Cross Laps  P1NP  Bone metastatic carcinoma
本文献已被 维普 等数据库收录!
点击此处可从《实用肿瘤学杂志》浏览原始摘要信息
点击此处可从《实用肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号